Model
Edge
Cero Therapeutics Holdings, Inc.
PBAX
Filing type
8-K
Filing date
Feb 12, 2026
Updated
Feb 13, 2026 ยท 2:35 PM
Copy reference
Filing
8-K
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Changing the Company's Accountant, Changes in Board, Management or Compensation
Exhibits
EX-4.1
FORM OF NOTE (FEBRUARY 2026)
EX-16.1
LETTER TO SECURITIES AND EXCHANGE COMMISSION FROM WOLF & COMPANY, P.C., DATED FEBRUARY 13, 2026